07:00 , Jul 10, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Lysine-specific demethylase 2B (KDM2B; JHDM1B) In vitro and mouse studies suggest inhibiting KDM2B could help treat breast cancer. In multiple breast cancer cell...
08:00 , Mar 10, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML) Lysine-specific histone demethylase 2B (KDM2B; JHDM1B) Studies in mice and in cell culture suggest that inhibiting KDM2B could help treat...